Surmodics Inc 's ROA from the third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Surmodics Inc 's ROA in the third quarter of 2025?
Surmodics Inc recorded a cumulative net loss of $-18 million during 12 months ending in the third quarter of 2025, resulting in a negative return on assets (ROA) of -10.4%.

However, within the Healthcare sector 293 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2025 quarter, so far to 3315, from total ROA ranking in the second quarter of 2025 at 3379.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2025) III. Quarter	(Mar 31 2025) II. Quarter	(Dec 31 2024) I. Quarter	(Sep 30 2024) IV. Quarter	(Jun 30 2024) III. Quarter
Y / Y Total Assets Change	-4.28 %	-10.72 %	-9.15 %	-2.38 %	3.08 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-18	-20	-14	-12	-1
Return On Assets (TTM)	-10.4 %	-11.59 %	-8.17 %	-6.4 %	-0.77 %
SRDX's Total Ranking	# 3315	# 3379	# 3763	# 3241	# 2759
Total Assets (TTM) in million	170	163	164	181	177
Seq. Total Assets Change	4.05 %	-0.32 %	-9.69 %	2.2 %	-2.95 %
Seq. Net Income Change	-	-	-	-	-

SRDX's 5 Years Annual ROA >> Back to SRDX Management Effectiveness >> Compare SRDX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 95
Sector	# 294
Overall	# 3271

Return On Assets Statistics
High	Average	Low
14.4 %	1.88 %	-21.47 %
(Sep 30 2013)		(Mar 31 2023)

Financial Statements
Surmodics Inc 's Assets	$ 170 million	SRDX's Balance sheet
Surmodics Inc 's Income	$ -5 million	Quarterly SRDX's Income Statement
SRDX's Income by Division		See SRDX's Income by Division

Annual Return On Assets	(Sep 30 2024) FY 2024	(Sep 30 2023) FY 2023	(Sep 30 2022) FY 2022	(Sep 30 2021) FY 2021	(Sep 30 2020) FY 2020
Y / Y Total Assets Change	-3.86 %	17.29 %	-18.62 %	15.3 %	5.57 %
Total Assets in million	179	186	158	195	169
Y / Y Net Income Change	-	-	-	277.29 %	-85.21 %
Net Income in million	-12	-2	-27	4	1
Annual Return On Assets	-6.46 %	-0.83 %	-17.22 %	2.18 %	0.67 %

SRDX's 5 Years Annual ROA >> Back to SRDX Management Effectiveness >> Compare SRDX ROA to its Competitors

More Return On Assets Ratios
SRDX's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SRDX's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SRDX's Competitors
Subscribers only: Roa for Surmodics Inc 's Suppliers
Subscribers only: Return On Assets for SRDX's Customers

You may also want to know
SRDX's Roi	SRDX's Inventory Turnover Ratio	SRDX's Growth Rates	SRDX's Dividend Comparisons
	SRDX's Profitability Ratios	SRDX's Asset Turnover Ratio	SRDX's Dividend Growth
SRDX's Roe	SRDX's Valuation Ratios	SRDX's Financial Strength Ratios	SRDX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2025, within Healthcare Sector

ROA

Date modified: 2026-08-29T17:14:28+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.